Sustained benefit of tadalafil in patients with pulmonary arterial hypertension with prior response to sildenafil: A case series of 12 patients
Authors:
- Edgar Lik-Wui TayETEdgar Lik-Wui Tay
- Michelle Koh Geok-MuiMGMichelle Koh Geok-Mui
- Margaret Choong Poh-HoonMPMargaret Choong Poh-Hoon
- James YipJYJames Yip
- 1 April 2008
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 125 (3) , 416-417
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Efficacy of Oral Tadalafil, a New Long-acting Phosphodiesterase-5 Inhibitor, for the Short-term Treatment of Pulmonary Arterial Hypertension in a DogJournal of Veterinary Medicine Series A, 2006
- Tadalafil pharmacokinetics in healthy subjectsBritish Journal of Clinical Pharmacology, 2005
- Sildenafil Citrate Therapy for Pulmonary Arterial HypertensionNew England Journal of Medicine, 2005
- Tadalafil in Primary Pulmonary Arterial HypertensionAnnals of Internal Medicine, 2004
- Clinical efficacy of sildenafil in primary pulmonary hypertensionJACC, 2004
- Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary HypertensionAnnals of Internal Medicine, 2002